SnRK2.8 is a member of the sucrose nonfermenting-related kinase family that is down-regulated when plants are deprived of nutrients and growth is reduced. When this kinase is over expressed in Arabidopsis, the plants grow larger. To understand how this kinase modulates growth, we identified some of the proteins that are phosphorylated by this kinase. A new phosphoproteomic method was used in which total protein from plants overexpressing the kinase was compared with total protein from plants in which the kinase was inactivated. Protein profiles were compared on two-dimensional gels following staining by a dye that recognizes phosphorylated amino acids. Candidate target proteins were confirmed with in vitro phosphorylation assays, using the kinase and target proteins that were purified from Escherichia coli. Seven target proteins were confirmed as being phosphorylated by SnRK2.8. Certain targets, such as 14-3-3 proteins, regulate as yet unidentified proteins, whereas other targets, such as glyoxalase I and ribose 5-phosphate isomerase, detoxify byproducts from glycolysis and catalyze one of the final steps in carbon fixation, respectively. Also, adenosine kinase and 60S ribosomal protein were confirmed as targets of SnRK2.8. Using mass spectrometry, we identified phosphorylated residues in the SnRK2.8, the 14-3-3 , and the 14-3-3 . These data show that the expression of SnRK2.8 is correlated with plant growth, which may in part be due to the phosphorylation of enzymes involved in metabolic processes.14-3-3 ͉ nutrient deprivation ͉ plant ͉ potassium T he mammalian AMPK (AMP-activated protein kinase), the yeast SNF (sucrose nonfermenting) 1 protein kinase, and the plant SnRK (SNF1-related protein kinase) are highly conserved and play broad roles in growth and metabolic responses to cellular stress (1). Mammalian cells sense glucose levels through the mammalian target of rapamycin kinase, which is part of an AMPK complex. AMPK is implicated in the development and treatment of metabolic disorders, including obesity and type 2 diabetes (2), and mutations in AMPK causes cardiac abnormalities (3). In yeast, SNF1 is required for regulation of glucose-responsive genes necessary for pseudohyphal growth in response to nutrient limitations (4) and for controlling the onset of meiosis in yeast (5). SNF1 provides a mechanism for crosstalk between metabolic pathways and cell cycle signaling processes (6). Mammal AMPK and yeast SNF1 act as energy-level sensors that function to regulate metabolism during low-energy conditions.